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ABSTRACT
In most organisms, the primary function of homolo-
gous recombination (HR) is to allow genome protec-
tion by the faithful repair of DNA double-strand
breaks. The vital step of HR is the search for
sequence homology, mediated by the RAD51 re-
combinase, which is stimulated further by proteins
mediators such as the tumor suppressor BRCA2.
The biochemical interplay between RAD51 and
BRCA2 is unknown in Leishmania or Trypanosoma.
Here we show that the Leishmania infantum BRCA2
protein possesses several critical features import-
ant for the regulation of DNA recombination at the
genetic and biochemical level. A BRCA2 null mutant,
generated by gene disruption, displayed genomic
instability and gene-targeting defects. Furthermore,
cytological studies show that LiRAD51 can no
longer localize to the nucleus in this mutant. The
Leishmania RAD51 and BRCA2 interact together
and the purified proteins bind single-strand DNA.
Remarkably, LiBRCA2 is a recombination mediator
that stimulates the invasion of a resected DNA
double-strand break in an undamaged template by
LiRAD51 to form a D-loop structure. Collectively, our
data show that LiBRCA2 and LiRAD51 promote HR
at the genetic and biochemical level in L. infantum,
the causative agent of visceral leishmaniasis.
INTRODUCTION
DNAdouble-strand breaks (DSBs) are one of themost cyto-
toxic lesions that can occur in the genomic DNA. In human
cells, these lesions are repaired by non-homologous end
joining (NHEJ) but also homologous recombination
(HR). In this context, HR protects the genome from
DNA translocations or rearrangements. Several studies
have demonstrated a role for RAD51 and BRCA2 in
both mitotic and meiotic recombination. BRCA2 plays a
pivotal role in controlling the function and localization of
RAD51 during HR, a central process for the maintenance
of genome stability and cancer prevention (1). The BRC
repeats located at the center of BRCA2 confer a very
sophisticated mode of regulation. Indeed, the BRC repeats
bind RAD51 and control RAD51 nucleoprotein filament
formation in conjunction with the BRCA2 DNA-binding
domain, whereas a BRC-unrelated RAD51-binding motif
located at the C-terminus of BRCA2 appears to stabilize
the filament (2–5). BRCA2 contains also a characteristic OB
(oligonucleotide/oligosaccharide-binding) pocket, which
consists of a highly curved five-stranded b-sheet that
closes on itself to form a b-barrel, which confers
single-strand DNA (ssDNA)-binding activity (6,7).
Orthologs of BRCA2 have been found in eukaryotes such
as human, mouse, rat, Xenopus, Caenorhabditis elegans,
Trypanosoma and Leishmania but this protein is absent
from yeast, archaea and bacteria (8). Saccharomyces
cerevisiae does not bear a BRCA2 homolog, a function
that might be replaced by RAD52. However, RAD52
orthologs have not been detected in Leishmania infantum,
although these enzymes have a central role in recombination
and DNA repair (9). Budding yeast or human RAD52
promote single-strand annealing of complementary
ssDNA independent of RAD51 (10,11) and enhance
RAD51-mediated strand invasion by direct interaction
with the recombinase RAD51 (12). Although the NHEJ
factors Ku70 and Ku80 have been identified in trypano-
somes (13,14), it is not clear whether these human parasites
possess a NHEJ activity as no DNA ligase IV and XRCC4
homologs were detected within their genomes (15).
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The most common view in the control of the HR
process is that HR should be suppressed up to a level
where genomic stability is maintained. However, organ-
isms such as Trypanosoma brucei use HR as a beneficial
mechanism for antigenic variation (16) or Leishmania for
drug resistance (17). First, it has been assumed that HR
and DSB formation play an important role in antigenic
variation. Variant surface glycoprotein (VSG) switching
allows some of the infecting T. brucei to evade the host
immune response, therefore allowing survival of the
parasite and new transmission to another mammal.
Analysis in T. brucei revealed that VSG switching fre-
quency is highly dependent on RAD51 and BRCA2
proteins. Moreover, it was shown that the induction of a
DSB adjacent to the 70-bp repeats upstream of the
transcribed VSG induced VSG switching. The switching
frequency was increased 250-fold compared to control
cells without an I-SceI recognition sequence. Interestingly,
VSG switching occurred through break-induced replica-
tion (16). Hence, understanding the biochemical role of
BRCA2 in HR might be beneficial in understanding
trypanosomatid diseases. Moreover, L. infantum amplify
regions of its genome upon drug selection by HR between
homologous repeated sequences (17).
The large size of the human BRCA2 protein (384 kDa)
poses a great technical challenge for biochemical analyses.
Amongst all BRCA2 proteins, Brh2 of Ustilago maydis,
has been extensively characterized because of its smaller
size (127 kDa). Brh2 binds D-loops specifically (18) and
promotes strand invasion in an homologous duplex (19).
Brh2 facilitates the second-end capture step in the DNA
DSB model, by enhancing the annealing of a second com-
plementary single-strand to the displaced strand of a
D-loop to form a duplexed D-loop (20). It was recently
reported that the human BRCA2 protein forms rings on
DNA (21), binds to approximately six RAD51 molecules
and promotes RAD51 filament formation on RPA-
covered ssDNAs (22). In addition, it stimulates RAD51-
mediated DNA strand exchange (23). To date, however,
D-loop formation was not performed for the human
BRCA2 protein (21–23) and evidence of human BRCA2
being able to stimulate RAD51-mediated D-loop forma-
tion is lacking.
The Rad51 gene from the parasite Leishmania major has
been identified previously (24). Comparative bioinfor-
matic analyses revealed that the size of the L. infantum
BRCA2 protein was about three times smaller (125 kDa)
than its human counterpart. Moreover, our analyses
revealed that LiBRCA2 possesses key features of the
BRCA2 family. We exploited the smaller size of the
Leishmania BRCA2 protein to better understand its
function in HR, along with the LiRAD51 recombinase.
MATERIALS AND METHODS
Nucleic acids
The L. infantum Brca2 and Rad51 genes were amplified by
PCR from genomic DNA as protein-encoding genes are
intronless in Leishmania. The sequences were identical to
the NCBI reference sequences A4HYJ9 and A4I3C9,
respectively. The LiBrca2 PCR fragment was obtained
with the combination of primers JYM1599 and
JYM1600 (Supplementary Table S1) and the purified
PCR fragment was cloned in a modified pFASTBAC1
plasmid (Invitrogen) encoding GST and His tags to yield
the GST–LiBRCA2–HIS construct. Similarly, LiRad51
was amplified with primers JYM1669 and JYM1670
(Supplementary Table S1) then cloned in a modified
pFASTBAC1 plasmid (Invitrogen) encoding GST to
generate the LiRAD51–GST construct. LiBRCA2–GFP
was obtained following the amplification of LiBrca2
with primers JYM1894 and JYM1896 (Supplementary
Table S1) and the resulting PCR product was cloned in
the Leishmania expression vector pSPaHYGaGFP.
Finally, the LiRAD51–DsRed version was generated
with primers JYM1899 and JYM1900 (Supplementary
Table S1), and the purified PCR product was cloned in
the pSP72aNEOa-DsRed vector (constructed by inserting
DsRed in pSP72aNEOa (25)).
Generation of the LiBrca2 null mutant
To generate a single knockout of LiBrca2 (e.g.
LinJ.20.0070 in geneDB see http://www.genedb.org/),
the entire ORF of LinJ.20.0070 was substituted by a
neomycin phosphotransferase cassette flanked by 50- and
30-regions of LinJ.20.0070. The upstream LiBrca2 region
was amplified with primers MOU1001 and MOU1002
(Supplementary Table S1), and the LiBrca2 downstream
region was obtained with primers combination MOU1003
and MOU1004 (Supplementary Table S1). Targeting
flanks were amplified from L. infantum genomic DNA
and ligated to theNEOmarker gene as previously reported
(26). An insertional inactivation strategy was performed
to target the second LiBrca2 allele. A polypyrimidine
stretch (Y)-hygromycin-a-tubulin fragment (YHYGa)
was obtained by PCR with the primers MOU1005
and MOU1006 of the Leishmania expression vector
psp72Yhygroa (27). The YHYGa purified fragment was
then fused with the 50- and 30-flanking regions of
LiBrca2 after their respective PCR amplification with
primers MOU1007 and MOU1008 (upstream region)
and MOU1009 and MOU1010 (downstream region)
(Supplementary Table S1). The final targeting cassette
was inserted into the ORF of LinJ.20.0070 by HR. For
episomal complementation of LinJ.20.0070, the LiBrca2
gene was amplified using 1 ng of L. infantum genomic
DNA, with two primers containing either XbaI (MOU
1011) or SalI (MOU1012) (Supplementary Table S1) re-
striction sites. The PCR product was first cloned in the
pGEM-T Easy vector then the construct was digested with
both restriction enzymes. The LiBrca2 fragment was
subcloned into the Leishmania expression vector
pSP72aZEOa (28) within the XbaI and SalI cloning
sites. All constructs were confirmed by DNA sequencing.
The empty vector pSP72aZEOa was transfected in
L. infantum wild-type cells (LiWT) and in the
LinJ.20.0070 null mutant (LinJ.20.0070/) and these
cells were used as controls.
Recombinants and transfectants were selected as fol-
lowing: 5 mg of both linear inactivation cassettes (neo or
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hyg) were obtained by PCR amplification, purified and
transfected into promastigotes by electroporation as pre-
viously reported (25). For plasmid transfection (episomal
complementation or empty vector), 10–20 mg was used.
Recombinants and transfectants were selected in the
presence of 300 mg/ml hygromycin B, 40 mg/ml G418
(Geneticin, Gibco-BRL) and 800 mg/ml zeocin
(Invitrogen) depending on the marker used. After 2–3
passages, cells resistant to the antibiotic selection were
cloned on SDM–agar plates (1%) in the presence of
20 mg/ml of G418 or 160 mg/ml of hygromycin B. Clones
were picked up after 7–10 days and used for analysis. PCR
analysis of three different clones after integration of the
HYG and NEO cassettes was done using primers pairs
a+b, c+d, e+f respectively MOU1007+MOU1110,
MOU1113+MOU1114, MOU1115+MOU1116 (Supple-
mentary Table S1).
Southern blot analysis
Genomic DNA of the selected clones was isolated using
DNAzol as recommended by the manufacturer
(Invitrogen). Digested genomic DNAs with ApaI and
ClaI were subjected to Southern blot hybridization with
[a-32P]dCTP-labeled DNA probes according to standard
protocols (29). All probes were obtained by PCR from
Leishmania genomic DNA or from plasmids containing
markers then purified appropriately before being labeled.
Transformation efficiency
We used the construct 50-GSH1-BLA-30GSH1 (26) to
target the single copy gene GSH1 on chromosome 18
and confer blasticidin resistance in order to monitor the
integration efficiency. Briefly, 4 107 cells of WT
pSP72aZEOa, LinJ.20.0070/ pSP72aZEOa, and
LinJ.20.0070/ pSP72aZEOa encoding LiBRCA2 were
transfected with 5 mg of the linear 50GSH1-BLA-30GSH1
construct and after 24 h following electroporation, cells
were preselected with 40 mg/ml blasticidin. After another
24 h cells were plated on SDM–agar plates (1% agar and
100mg/ml blasticidin). LiWT cells and complemented cells
were plated at a density of 5 106 cells/plate and the null
mutant LinJ.20.0070 / at 7 106 cells. All these strains
were also transfected with an empty plasmid
(pSPaBLAaGSH1) as a control. Colonies were counted
after 10–15 days of plating. Genomic DNA was extracted
from selected clones using the DNAzol method
(Invitrogen) and integration of the BLAST marker gene
(BLA) into the GSH1 chromosomal locus was confirmed
by PCR (primers MOU1117 and MOU1118)
(Supplementary Table S1).
Western blotting of LiRAD51 and LiBRCA2 in
Leishmania protein extracts
Leishmania infantum promastigotes were grown in SDM–
79 medium supplemented with 10% heat-inactivated
fetal bovine serum, 5 mg/ml hemin and 5 mM biopterin at
pH 7.0, 28C up to the logarithmic phase (OD600 nm 0.5).
Cultures containing 5 106 cells resuspended in 5ml
medium were prepared with 12 mg/ml of phleomycin
and incubated at 28C for 0, 24, 48, 72 and 96 h. At
each time point, the cells were centrifuged at 3000 rpm
for 5min, washed once with HEPES/NaCl buffer
(21mM HEPES, pH 7.2, 137mM NaCl, 5mM KCl,
0.7mM Na2HPO4, 6mM glucose) then resuspended in
30 ml of 2 Laemmli buffer. The protein samples (20 ml)
were loaded onto a 8% SDS–PAGE and analyzed by
western blot using the indicated antibodies. LiBRCA2
and hRAD51 antibodies were generated in the laboratory
and were used at 1:5000 concentration whereas the
a-tubulin antibody was purchased from Abcam and used
at 1: 2500 dilution.
Protein sequence analysis
The domains presented in the Supplementary Figure S1
were identified using pfam with an E-value cutoff of 10
(30). The phylogenetic tree was generated by first
gathering BRC repeat sequences for each different
species. The sequences corresponding to the BRC repeat
domain in each protein was extracted and numbered in
function of their location relative to the N-terminal of
the protein so the closest domain in N-terminal is
assigned number 1. The alignment used in
Supplementary Figure S1B is the alignment reported by
hmmsearch when aligning sequence to the model. The
phylogenetic tree of Supplementary Figure S1B was
generated within Jalview using Neighbor-joining with
the Blosum 62 scoring matrix (31). The tree reported in
Supplementary Figure S1C was generated on a selected
portion of global multiple alignment produced using the
software MAFFT in FFT-NS-i mode (32,33). We selected
the portion located just before OB1 (human starting
amino acid S2590). The tree building option on the
MAFFT website was used to produce the tree of
Supplementary Figure S1C using the Neighbor-joining
method with JTT substitution model without heterogen-
eity among sites and 1000 bootstraps.
Fluorescence microscopy
Promastigote cells expressing the green fluorescence
protein (GFP)-fusion proteins or DsRed-fusion proteins
were first washed with HEPES/NaCl buffer then
incubated 10min with 0.5 mg/ml DAPI (Sigma) in the
dark. The cells were washed twice with HEPES/NaCl
buffer and immobilized in HEPES/NaCl buffer containing
10% glycerol. Live parasites were mounted on microscope
slides with coverslips sealed with nail varnish and air-dried
for 15min. The slides were visualized by epifluorescence
microscopy. Bright field and fluorescence images were
taken using a Nikon Eclipse TE300 inverted microscope
equipped with a Photometrics coolSNAPfx camera.
Visualization of the DAPI, GFP and DsRed fluorophores
were achieved using respectively 340/380 nm, 460/500 nm,
532/588 nm excitation filters and 435/485 nm, 510/560 nm,
607/683 nm emission filters with a 100 objective. The
images were processed using ImageJ version 1.42
(National Institutes of Health, USA; http://rsb.info.nih.
gov/ij).
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Figure 1. Inactivation of LiBrca2 and phenotypic analyses. (A) Schematic representation of LiBRCA2 in comparison to human BRCA2. BRC
repeats, OB-folds, and RAD51-binding regions are shown. (B) Schematic representation of the LiBrca2 chromosomal locus (top) and inactivation
cassettes with the neomycin phosphotransferase (Neo, middle) and hygromycin phosphotransferase (Hyg, bottom) markers. The position of the
primers pairs (a+b, c+d, e+f) used in (C) is depicted. (C) PCR analysis of three different clones after integration of the HYG and NEO cassettes.
Clone in lane 1 is identical to L. infantum WT (e.g. no integration), clone in lane 2 has a NEO insertion in one allele, and clone in lane 3 has both
NEO/HYG insertions. (D) Southern blots of three different clones digested with ApaI (A) and ClaI (C) after hybridizing with a 700 bp specific
LiBrca2 (left), NEO (middle) and HYG probes (right) on the DNA isolated from the three clones described in (C). (E) Growth retardation of
LiBrca2 null mutants grown as promastigotes. Growth of L. infantum WT (closed circles), DKO LiBrca2 (closed squares), and DKO LiBrca2
complemented with a plasmid expressing LiBRCA2 (closed triangles), was measured over time. (F) Inactivation of LiBrca2 impairs gene targeting.
Gene targeting was measured in L. infantum WT, DKO LiBrca2 and DKO LiBrca2 complemented with a plasmid expressing LiBRCA2. (G) DKO
LiBrca2 cells display genomic instability. Pulsed field gel electrophoresis was performed on L. infantum WT cells (lanes 2 and 3), DKO LiBrca2 (lane
4) and DKO LiBrca2 complemented with a plasmid expressing LiBRCA2 (lane 5). The arrow shows a chromosomal band present in WT cells but
absent in the other strains. Molecular weight markers (BioRad, S. cerevisiae DNA size standard) were used in lane 1.
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Purification of human RPA, human RAD51 and
L. infantum RAD51 and BRCA2
The human RPA protein was purified according to (34),
and human RAD51 was purified as described in (35). GST–
LiBRCA2–His was purified from baculovirus-infected Sf9
cells. Sf9 insect cells (1 l culture) were infected with the
BRCA2 baculovirus for 3 days at 27C. The cell pellet
(600ml) was resuspended in 18ml of PBS washing buffer
[300mM NaCl, 1mM EDTA, 0.05% Triton, 1mM DTT
in 1 PBS (GIBCO)] containing protease inhibitors
PMSF (1mM), aprotinin (0.019 UIT/ml) and leupeptin
(1mg/ml). The suspension was lysed using a Dounce hom-
ogenizer (15 strokes), sonicated three times for 30 s on ice.
Insoluble material was removed by centrifugation in small
aliquots of 1ml (10min, 13 000 rpm, 4C). An amount of
1ml of glutathione sepharose beads (GE Healthcare) was
added to the combined supernatant and incubated during
1h at 4C. The beads were washed two times with 1 PBS
then incubated for 30min in HSP buffer (5mM ATP,
15mM MgCl2 in 1 PBS) at 4C. The beads were
further washed two times with 1 PBS containing
500mM NaCl and one more time in the Talon buffer
(50mM NaHPO4 pH 7.0, 500mM NaCl, 10% glycerol,
0.05% Triton, 5mM imidazole). The LiBRCA2 protein
was eluted by cleavage with PreScission protease
(60U/ml, GE Healthcare) during 3h at 4C in the Talon
buffer. The supernatant was added on 200ml of Talon resin
(Clontech) and incubated for 30min at 4C. The resin was
washed two times with 4ml of Talon buffer containing
30mM imidazole and one time with 80mM imidazole.
LiBRCA2 protein was eluted in buffer containing
500mM imidazole and dialyzed in storage buffer (20mM
Tris–Acetate, pH 8.0, 200mM KOAc, 10% glycerol, 1mM
EDTA, 0.5mM DTT). The GST–LiRAD51 protein was
purified as for GST–LiBRCA2–His but excluding the
Talon purification step. The beads were washed in
PreScission washing buffer (50mM Tris–HCl pH 7.4,
150mM NaCl, 1mM EDTA, 1mM DTT, 0.05% Tween
20) before cleavage. The LiRAD51 protein was eluted fol-
lowing an overnight cleavage at 4C with 60U/ml of
PreScission protease (GE Healthcare) in PreScission
washing buffer.
Gel-filtration analysis
The molecular mass of LiRAD51 (20 mg) and LiBRCA2
(5mg) were determined by gel filtration using 250 mg of a
series of protein standards; bovine thyroglobulin
(670 kDa), bovine gamma globulin (158 kDa), chicken ov-
albumin (44 kDa), horse myoglobin (17 kDa) and vitamin
B-12 (1.35 kDa). Purified proteins were analyzed on a
FPLC Explorer 10 system fitted with a 24ml Superdex
200 PC 3.2/30 column (Pharmacia) equilibrated in gel-
filtration buffer (25mM Tris–HCl pH 7.5, 150mM KCl,
5% glycerol, 1mM DTT). Fractions (500 ml) were col-
lected and analyzed by SDS–PAGE followed by western
blotting with a monoclonal anti-Histidine antibody (BD
Biosciences) for LiBRCA2 or a polyclonal anti-human
RAD51 to detect LiRAD51.
D-loop assays
The D-loop assay with 30-tail DNA was conducted essen-
tially as described (36). A linear duplex DNA was
prepared by restriction digestion of pPB4.3 DNA
(4.3 kb) (37) with SmaI. Linear DNA with 30-tails
(200 nt in length) were generated by treatment of
linearized pPB4.3 DNA (100mg) with T7 gene 6 exonucle-
ase (830 units, 1min at 25C) in 800 ml reaction volume
containing 20mM Tris–Acetate pH 7.9, 50mM KOAc
pH 7.9, 10mM Mg(OAc)2 and 1mM DTT. Exonuclease
digestion was stopped by extraction with phenol/chloro-
form. Finally, the resected DNA was purified by gel elec-
trophoresis through a 0.8% (w/v) agarose gel and
recovered by electroelution. 32P-labeled 30-tailed DNA
substrate (1 mM nucleotides) was incubated for 5min at
37C with the indicated concentration of LiRAD51 and/
or LiBRCA2 in 25mM Tris–Acetate pH 7.5, 1mM DTT,
20mM creatine phosphate, 5U/ml phosphocreatine
kinase, 1mM ATP and 0.5mM MgCl2 in 10 ml. CsCl-
purified pPB4.3 replicative form I DNA (300mM) was
added and the reaction was incubated for 1 h 30min.
The reaction was quenched with the addition of one-fifth
volume of stop buffer (20mM Tris–Cl pH 7.5 and 2mg/ml
proteinase K) followed by a 30min incubation period at
37C. Labeled DNA products were analyzed by electro-
phoresis through a 0.8% TAE 1 agarose gel, run at 65V,
dried onto DE81 filter paper and visualized by
autoradiography.
DNA-binding assays
Reactions (10 ml) contained 100 nM of 32P-labeled DNA
oligonucleotides (e.g. primer JYM925 for the ssDNA
assay and primers JYM925/JYM945 for the double-strand
DNA (dsDNA) assay, see Supplementary Table S1
for oligonucleotide sequences) and LiBRCA2 and/or
LiRAD51, at the indicated concentrations, in binding
buffer (20mM Triethanolamine–HCl pH 7.5, 50mM
NaCl, 2mM MgCl2, 2mM ATP and 1mM DTT).
Proteins were added to reactions and incubated at 37C
for 10min, followed by 15min of fixation with 0.2%
glutaraldehyde. Reactions were loaded onto a 0.8% TBE
1 agarose gel.
Single-strand annealing reactions
Reactions (10 ml) contained denatured 32P-labeled
dsDNA (50 nM) with LiRAD51 or/and LiBRCA2, at
the indicated concentrations, in HEPES buffer (20mM
HEPES pH 7.5, 5mM Mg(CH3COO)2, 2mM ATP,
5mM DTT and 100mM NaCl). Incubation was per-
formed at 20C for 10min. The reaction products were
deproteinized by the addition of one-fifth volume of stop
buffer (20mM Tris–Cl pH 7.5 and 2mg/ml proteinase K)
followed by a 10min incubation period at 20C. Labeled
DNA products were analyzed by electrophoresis (8%
PAGE gel with TBE1X buffer, run at 150V for 3 h), the
gel was dried onto DE81 filter paper and visualized by
autoradiography.
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Immunoprecipitation
Immunoprecipitation from purified proteins were per-
formed as follows. Purified LiBRCA2 (750 ng) and
hRPA (1 mg) were incubated in 100ml of IPR buffer
(20mM Tris–acetate pH 8.0, 125mM KOAc, 0.5mM
EDTA, 0.5% NP40, 10% glycerol, 0.1mg/ml BSA) for
30min at 37C. An amount of 1 mg anti-Histidine
(Clontech) was added for 30min at 4C followed by the
addition of 15 ml protein A/G sepharose beads (Pierce) for
30min. Immunoprecipitates were washed four times in
IPR buffer containing 300mM KOAc and visualized by
western blotting using the indicated antibodies.
Sf9 insect cells (20ml) were coinfected with the
LiBRCA2 and LiRAD51 baculoviruses (dilution 1/150)
for 2 days at 27C. The cell pellet was resuspended in
5ml of IP100 buffer (20mM Tris–Acetate pH 8.0,
100mM KOAc, 0.5mM EDTA, 0.5% NP40, 10%
glycerol, 0.1mg/ml BSA, 1mM DTT) containing
protease inhibitors PMSF (1mM), aprotinin (0.019UIT/
ml) and leupeptin (1mg/ml). The suspension was sonicated
two times for 10 s. Insoluble material was removed by cen-
trifugation in small aliquots of 1ml (10min, 13 000 rpm,
4C). 2 mg anti-Histidine (Clontech) was added to 1mg of
protein and incubated during 2 h at 4C followed by the
addition of 15 ml protein A/G sepharose beads (Pierce) for
1 h at 4C. Immunoprecipitates were washed four times in
the IP100 buffer with the indicated concentration of
KOAc and visualized by western blotting using the
indicated antibodies.
Biotin pull-down assay
Magnetic beads (Roche) containing 50-biotinylated ssDNA
polydT 83-mer (corresponding to the final concentration of
1 mMnucleotide) were pre-incubated with a blocking buffer
(25mM Tris–acetate pH 7.5, 40mM KOAc, 1mM DTT,
0.02% Igepal and 10mg/ml BSA) for 20min at 37C. The
beads were captured with the magnetic particle separator,
washed once with DC buffer (25mM Tris–Acetate pH 7.5,
40mM KOAc, 1mM DTT, 0.02% Igepal, 1mg/ml BSA,
5mM ATP and 0.5mM MgCl2) and resuspended in the
same buffer. hRPA was added (17 ml) and the reaction
was incubated for 5min at 37C. Then LiRAD51
(200 nM) was added and the reaction was incubated for
5min at 37C. Finally, the indicating concentration of
LiBRCA2 protein was added (in 20 ml) and the reaction
was incubated further for 5min at 37C. The beads were
captured and were washed twice with 50 ml of washing
buffer (25mM Tris–Acetate pH 7.5, 40mM KOAc,
1mM DTT, 0.02% Igepal, 5mM ATP and 0.5mM
MgCl2). Finally, 15 ml of 2 Laemmli buffer was added
and beads were heated 5min at 95C. The beads were
captured again and the supernatants were loaded onto a
8% SDS–PAGE Ruby (Invitrogen) and visualized by UV.
RESULTS
Bioinformatic analyses of LiBRCA2
Analysis of the Leishmania genome suggested that
LinJ20.0070 is a BRCA2 ortholog. We scrutinized
whether LiBRCA2 possessed features reminiscent of the
BRCA2 family of enzymes. We started by first detecting
all the significant protein domains within the selected list
of BRCA2 proteins using pfam (30) with a permissive
E-value. We detected two BRC repeats, one OB-fold
and also at least one putative zf–RanBP (Zn-finger in
Ran-binding protein) domain for every Leishmania
species analyzed (Supplementary Figure S1B). We also
detected 15, 2, 7, 8 and 4 BRC repeats for T. brucei,
Trypanosoma cruzi, mouse, human and Arabidopsis, re-
spectively. The OB-fold domain could be detected in all
proteins analyzed. The helical domain could only be
detected in mouse, human and Arabidopsis and the
Tower domain is only present in mouse and human.
Since the BRC repeats are present in all the BRCA2
proteins, we were interested to study the evolutionary
link between the BRC repeats of all the different species.
For this purpose we extracted the BRC repeats detected
by pfam and aligned them to produce a phylogenetic tree
(Supplementary Figure S1A). All the first BRC repeats of
Leishmania are clustering together with all the BRC
repeats of T. brucei or cruzi. The second BRC repeats of
Leishmania are forming a cluster with the two first BRC
repeats of Arabidopsis. The two BRC repeats of
Leishmania are within a cluster also composed of mouse
and human BRC 3, 4, 7 and 8. We hypothesized that the
two BRC repeats of all Leishmania species analyzed
(Supplementary Figure S1A and S1B) are related to the
mouse and human BRC repeats 3, 4, 7 and 8.
Furthermore, we analyzed globally the evolution of the
BRCA2 proteins with a phylogenetic tree produced from
an alignment of all the BRCA2 proteins. We can observe
from Supplementary Figure S1C that the L. major and
L. donovani are the most similar form of BRCA2
followed by L. infantum and L. braziliensis. Collectively,
these bioinformatic analyses strongly suggested that
L. infantum possesses a BRCA2 homolog at amino acid
and phylogenic levels. A schematic representation of
LiBRCA2 in comparison to human BRCA2 is depicted
in Figure 1A.
Inactivation of LinJ.20.0070, the Leishmania
BRCA2 gene
Having established that L. infantum contains an homolog
of BRCA2, we generated a LiBrca2 null mutant. The
BRCA2 ortholog LinJ.20.0070 is a single copy gene. In
an attempt to inactivate LinJ.20.0070, one gene inactiva-
tion cassette with neomycin phosphotransferase (NEO)
and one gene disruption cassette with hygromycin
phosphotransferase (HYG) marker (Figure 1B) were
prepared. Linear NEO or HYG fragments were trans-
fected into L. infantum and recombination events of
clones selected on agar plates were followed by PCR re-
actions and Southern blot hybridizations (Figure 1C and
D). Digestion with ApaI and ClaI should yield a 3.3-kb
band in WT, while replacing one allele with NEO should
yield a 1.7-kb fragment hybridizing to a 30-UTR probe.
Insertional inactivation with YHYGa into the second
LinJ.20.0070 allele of LinJ.20.0070/NEO cells and
hybridizing with the same probe should yield a single
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4.7-kb band. Five clones from each independent transfec-
tion were selected. The DNA of one such representative
LinJ.20.0070/NEO (LinJ.20.0070+/) and NEO/HYG
(LinJ.20.0070/) clone was isolated, analyzed by PCR
using primers (a–f) (Figure 1B). The use of primers a
and b should lead to a fragment of 1.7-kb in the WT
and the single knockout LinJ.20.0070 should lead to a
3-kb fragment upon insertion of HYG (Figure 1B
and C). The integration of NEO and HYG at their hom-
ologous locus were confirmed by primer pairs c+d and
e+f, respectively. The DNA of these representative
LinJ.20.0070/NEO and NEO/HYG clones were digested
with ApaI and ClaI and analyzed by Southern blots after
hybridizing with a 30-UTR LinJ.20.0070 probe, NEO and
HYG probes. Bands of the expected size hybridizing with
all the probes were observed (Figure 1D, lanes 1–3), con-
firming the generation of a BRCA2 L. infantum null
mutant, termed DKO LiBrca2.
Phenotypes of LiBrca2 null mutants
Although deletion of BRCA2 in mouse leads to an embry-
onic lethality phenotype (38), the LiBrca2 mutants were
viable. LiBrca2 null mutants, adapted to in vitro culture,
had a specific growth retardation even when grown as
promastigotes in SDM medium when compared to
wild-type cells (WT) (Figure 1E). This growth retardation
was rescued upon the re-introduction of an episomal con-
struct encoding BRCA2 (DKO LiBrca2 complemented).
We have succeeded in generating an independent BRCA2
null mutant and observed the same growth defect (data
not shown).
Since gene disruption in Leishmania is mediated by
double crossed-over HR, we sought to determine
whether the loss of BRCA2 would decrease the efficiency
of HR. This was assayed by measuring the transformation
efficiencies of promastigotes transfected with the linear
construct 50-GSH1-BLA-GSH1-30 (26) which integrates a
blasticidin deaminase cassette into the GSH1 locus on
chromosome 18. There was at least a 10-fold decrease in
the transformation frequency, as determined by colony
numbering, when compared to WT (Figure 1F). Adding
back an episomal BRCA2 increased the number of
colonies at least to the wild-type levels and in one set of
experiments to 6-fold increase in colony numbers. The
number of episomal copies per cell can be variable,
which might explain the differences between each experi-
ment. The correct integration of the GSH1/BLAS cassette
was tested by PCR in selected colonies (data not shown).
BRCA2 inactivation in mammalian cells causes accu-
mulation of aberrant chromosomes, including gross
chromosomal rearrangements occurring from chromo-
somal loss, breakage or translocations (39). The karyotype
of the L. infantum BRCA2 null mutant was analyzed by
pulsed field gel electrophoresis. Size variations were
observed in chromosomes between 365 and 450 kb in
DKO LiBrca2 (Figure 1G, lane 4) compared to WT cells
(Figure 1G, lanes 2 and 3). Reintroduction of BRCA2 in
the null mutant did not restore chromosome integrity
(Figure 1G, lane 5).
LiRAD51 expression is modulated by DNA damage
To date, it is unclear to what extent HR proteins are ex-
pressed in L. infantum. The expression of LiBRCA2 and
LiRAD51 was monitored over time using western blotting
in mock- or phleomycin-treated cells (Figure 2A). To do
this, we used antibodies raised against LiBRCA2 and
human RAD51 that recognized LiBRCA2 and
LiRAD51, respectively. LiRAD51 and hRAD51 are
74.5% similar and 63% identical at the amino acid level
(Supplementary Figure S2). The proteins recognized by
the antibodies were at the predicted molecular weight,
41 kDa for LiRAD51 and 125 kDa for LiBRCA2. The
levels of LiBRCA2 did not fluctuate over time in cells
treated with the DNA damaging agent phleomycin.
However, the levels of LiRAD51 were vastly induced
96 h after DNA damage. This observation is in accordance
to the induction of LmRAD51 expression in L. major
promastigotes after phleomycin treatment (24).
In vivo localization of LiBRCA2
In human cells, RAD51 and BRCA2 are known to accu-
mulate as foci at DNA damage sites. The formation of
RAD51 foci is impaired in BRCA2-deficient cells.
Furthermore, cell fractionation assays using CAPAN-1
cells (which contains BRCA2 6174delT, a truncated
version), revealed that RAD51 is present in majority in
the cytoplasm, rather than the nuclear fraction (2). We
therefore investigated whether these functions are
conserved in Leishmania species. To do this, we expressed
LiRAD51 fused to DsRed and LiBRCA2 fused to GFP.
When both LiBRCA2–GFP and LiRAD51–DsRed were
expressed in WT Leishmania cells, both LiRAD51 and
LiBRCA2 colocalized in the nucleus (Figure 2B and
Supplementary Figure S3A). The expression of GFP or
DsRed alone in L. infantum lead to a much different
pattern of staining than LiBRCA2–GFP and LiRAD51–
DsRed (Supplementary Figure S3B). Interestingly,
LiRAD51 was no longer found in the nucleus in the
absence of LiBRCA2, but in the cytosol as part of
several punctuated stained regions (Figure 2C and
Supplementary Figure S3C). These results show that
LiBRCA2, like human BRCA2, control the nuclear accu-
mulation of LiRAD51.
Expression and purification of L. infantum RAD51
and BRCA2
To open the door to biochemical studies of L. infantum
RAD51 and BRCA2, we purified these proteins to homo-
geneity. First, the LiRAD51 and LiBRCA2 genes were
amplified by PCR from L. infantum genomic DNA and
cloned in pET16b vector. Following expression of
LiBRCA2 in Escherichia coli, very low expression was
achieved, and LiBRCA2 was highly degraded after
Talon purification (data not shown). Therefore, we
developed a two-step affinity purification procedure to
purify full length LiBRCA2 without any degradation
products. LiBrca2 gene was cloned in a modified
pFASTBAC vector to add, respectively, a glutathione-
S-transferase tag at the N-terminus and a 10-histidine
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tag at the C-terminus of the proteins. Recombinant
baculoviruses were used to infect SF9 insect cells,
followed by the purification of the recombinant BRCA2
protein. A cell lysate expressing GST–LiBRCA2–His was
subjected to GST affinity purification followed by GST
cleavage with PreScission protease and purification on
Talon beads. Opposite to LiBRCA2, LiRAD51 was well
expressed in insect cells and purified by GST affinity puri-
fication followed by PreScission cleavage of the GST tag.
This led to >95% pure preparations of both LiBRCA2
and LiRAD51 (Figure 3A).
The native molecular weight of purified LiBRCA2 and
LiRAD51 were determined by gel filtration through
Superdex 200 (Figure 3B). Similar to human RAD51 (2),
two peaks were observed, in fractions 18–20 (correspond-
ing to an averaged molecular weight of 350 kDa) and in
fractions 28–29 (corresponding to monomeric LiRAD51).
LiBRCA2 eluted in fractions 14–20, with a peak observed
A
B
C
Figure 2. Expression and cytological analysis of LiRAD51 and LiBRCA2. (A) Phleomycin treatment induces LiRAD51 expression in L. infantum
WT cells. Lysates from either untreated (no drug) or phleomycin-treated L. infantum WT promastigotes were subjected to western blotting with
anti-LiBRCA2, anti-hRAD51 or a-tubulin antibodies. Purified (Pur) LiBRCA2 or LiRAD51 (30 ng) are also shown. pAb, polyclonal antibody; mAb,
monoclonal antibody. (B) Cytological analysis of LiBRCA2–GFP, LiRAD51–DsRed, in WT L. infantum in the absence of exogenous DNA damage.
(C) Localization of LiRAD51–DsRed in DKO LiBrca2 in the absence of exogenous DNA damage. The kinetoplast (darker stained disk-shaped
structure) and nucleus (lighter stained disk-shaped structure) are stained with DAPI.
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at fractions 17–18 indicative of multimeric forms. This is
in agreement with the observation that human BRCA2
forms multimeric rings (21).
As LiBRCA2 mediates the recruitment of the recom-
binase LiRAD51 to the nucleus, we therefore tested
the possibility that both proteins interact. Using
coimmunoprecipitation assays, we observed a co-
complex between LiRAD51 and LiBRCA2 (Figure 3C).
The interaction between LiBRCA2 and LiRAD51 was
highly resistant to salt washes (Figure 3C, lanes 3–6). It
has been shown that BRC repeats are involved in the
interaction between BRCA2 and RAD51. Leishmania
infantum possesses two BRC repeats located at its
N-terminus (Figure 1A and Supplementary Figure S1).
To test whether LiRAD51 interacts with the N-terminus
of LiBRCA2, the LiBRCA2 N-terminal domain
(LiBRCA2–B1–His, amino acids 1–122) was coexpressed
with LiRAD51 in insect cells, followed by immunopre-
cipitation analysis (Figure 3D). A co-complex between
LiBRCA2–B1–His and LiRAD51 was observed, suggest-
ing that the interaction between LiBRCA2 and LiRAD51
is mediated through the BRC repeats.
LiRAD51 binds DNA, promotes single-strand annealing
and strand invasion
As a prerequisite for HR activities, RAD51 binds DNA.
Escherichia coli RecA protein shows a high affinity for
ssDNA compared with duplex DNA, while RAD51
protein binds both ssDNA and dsDNA (40). Using
electromobility shift assays, we found that LiRAD51
showed similar DNA binding to hRAD51, binding
5’-32P-end-labeled single- and dsDNA with a better
affinity for ssDNA (Figure 4A and B, compare lanes 3
and 4). Having established conditions under which
LiRAD51 bound DNA, we next investigated their
ability to promote single-strand annealing. As shown
with Schizosaccharomyces pombe RAD51 (41), LiRAD51
promoted single-strand annealing of complementary
ssDNAs of 60 nt. While low levels of spontaneous strand
annealing was observed in the control alone (18.2%),
LiRAD51 formed efficiently renatured DNA products
(57.3%) (Figure 4C).
As it is the first time that LiRAD51 is analyzed bio-
chemically, it was important to compare its relative
activity to human RAD51. First, both proteins were
A
B
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Figure 3. Purification of L. infantum RAD51 and BRCA2. (A) SDS–PAGE of purified LiRAD51 and LiBRCA2. Purified proteins (400 ng) were
loaded on a 8% SDS–PAGE, run then stained with Coomassie blue. Lane 1, molecular weight markers (Bio-Rad); lane 2, purified LiRAD51; lane 3,
purified LiBRCA2. (B) Native molecular masses of purified LiRAD51 and LiBRCA2 as determined by gel filtration through Superdex 200 columns.
Eluted fractions 12–35 are presented. Size standards (670, 150 and 44 kDa) are indicated. The upper panel was reacted with an anti-hRAD51
antibody and the bottom panel was revealed with an anti-His antibody. (C) LiBRCA2 interacts with LiRAD51. Sf9 cells were coinfected with
LiRAD51–GST and LiBRCA2–His baculoviruses, followed by immunoprecipitation with IgG alone (lane 2) or anti-His antibody (lanes 3–6). The
protein complexes were washed with buffer containing increasing salt (KOAc) concentration, as indicated. Eluted proteins were run onto an
SDS–PAGE along with the whole cell extract (lane 1). Blots were reacted with an anti-hRAD51 (upper panel) or anti-His (bottom panel) antibodies.
(D) The N-terminus of LiBRCA2 (LiBRCA2–B1) interacts with LiRAD51. Immunoprecipitations were conducted as described in (C) from Sf9 cells
coinfected with LiRAD51–GST and LiBRCA2–B1-His baculoviruses. Lane 1, whole cell extract; lane 2, immunoprecipitations with an anti-His
antibody alone; lane 3, immunoprecipitations with IgG alone; lane 4, immunoprecipitations with an anti-His antibody. Blots were reacted with
anti-hRAD51 polyclonal antibody (upper panel) or with an anti-His monoclonal antibody (bottom panel).
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quantified to insure that equal amounts of proteins were
used in the following experiments (Figure 4D). Since re-
combination is thought to be initiated by DNA that
contains single-stranded tails and these substrates would
be subsequently used in D-loop assays, we analyzed the
binding of both LiRAD51 and hRAD51 to these sub-
strates. While hRAD51 formed complexes of relatively
homogeneous size, we observed the formation of
LiRAD51–DNA networks that tended to smear up the
gel (Figure 4E). This result is characteristic of the for-
mation of networks containing a variable number of
protein and DNA molecules. A key step in HR is the
formation of a D-loop structure, characterized by the
invasion of an ssDNA substrate into a homologous
duplex DNA (Figure 5A). D-loop assays were performed
with long 30-tailed DNA substrate and homologous super-
coiled DNA in magnesium buffer. Adding purified
LiRAD51 and human RAD51 (200–1200 nM) to these
substrates led to an increase of D-loop products in a con-
centration dependent manner. Quantification of the
reaction revealed that LiRAD51 was more efficient than
human RAD51. At lower concentration (Figure 5B,
compare lanes 3–5 and 14–16), LiRAD51 was at least
3-fold more efficient than hRAD51. These results show
that LiRAD51 is a functional recombinase, homologous
to hRAD51.
LiBRCA2 controls LiRAD51 DNA binding
Next, we investigated the DNA-binding properties of
LiBRCA2. Similar to hBRCA2 (21), LiBRCA2 bound
ssDNA in a concentration-dependent manner, whereas it
did not form stable complexes with dsDNA (Figure 6A
and B). Interestingly, LiBRCA2 catalyzed the annealing
of complementary ssDNAs (Figure 6C). Having estab-
lished LiBRCA2 DNA-binding properties, we next
tested whether LiBRCA2 affects the DNA-binding
affinities of LiRAD51. Using conditions where
LiBRCA2 binding to DNA was minimal (5–20 nM) we
observed a significant increase in LiRAD51 binding on
ssDNA upon the addition of LiBRCA2 (Figure 6D). In
comparison, LiBRCA2 inhibited the loading of LiRAD51
on dsDNA (Figure 6E).
In order to better understand how LiBRCA2 stimulates
LiRAD51 DNA-binding ability, we purified a N-terminal
fragment of LiBRCA2 encompassing amino acids 1–122.
This truncation comprises the BRC repeats, but not the
OB-fold ssDNA-binding domain. It was recently shown
that the BRC5, 6, 7, 8 repeats of human BRCA2 stimu-
lates RAD51 to bind ssDNA (42). At a concentration
of 30 nM, 12.1% of ssDNA was bound by LiRAD51
(Figure 6F, lane 2). However, when this reaction was
supplemented by the LiBRCA2 fragment B1 (10–
125 nM), LiRAD51 bound ssDNA more strongly at all
LiBRCA2–B1 concentrations (Figure 6F, lanes 4–9),
although the stimulation of LiRAD51 was more effective
at low concentration. Since LiBRCA2–B1 does not bind
DNA by itself (Figure 6F, lane 3), this result suggests that
LiBRCA2–B1 stimulates LiRAD51–DNA binding
through its BRC motifs.
Stimulation of LiRAD51 by LiBRCA2
and mediator function
By definition, a recombination mediator assists RAD51 to
displace the replicative protein A (RPA) to allow RAD51
A
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Figure 4. DNA-binding activity of purified LiRAD51. (A) LiRAD51 binds ssDNA. Lanes 1–6, a P32-labeled-60-mer ssDNA was incubated with
increasing concentrations of LiRAD51 (0–1000 nM). (B) LiRAD51 binds dsDNA. Lanes 1–6, a P32-labeled-60-mer dsDNA was incubated with
increasing concentration of LiRAD51 (0–1000 nM). (C) LiRAD51 is proficient in single-strand annealing. Lane 1, purified 60-bp duplex DNA.
Reactions contained denatured 60-bp duplex DNA in buffer with no protein (lane 2) or with purified LiRAD51 (25–625 nM), lanes 3–10. The
percentage of annealing is indicated at the bottom. (D) SDS–PAGE of purified LiRAD51 (lane 2) and human RAD51 (lane 3). Molecular weight
markers (Bio-Rad) were run in lane 1. Proteins (300 ng) were loaded on a 10% SDS–PAGE and stained with Coomassie blue. (E) LiRAD51 and
human RAD51 show different 30-tailed DNA-binding profiles. Reactions contained labeled 30-tailed DNA with no protein (lane 1); with LiRAD51
(lane 2); or human RAD51 (lane 3). The asterisk represents annealed 30-tailed molecules.
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to polymerize as nucleoprotein filaments (43,44). It was
previously shown that the Ustilago maydis BRCA2
homolog acts as a recombination mediator (45). We there-
fore tested whether LiBRCA2 assisted RAD51 to displace
hRPA. In the absence of hRPA, LiRAD51 bound beads
coated with ssDNA (Figure 7A, lane 4). The addition of
hRPA prevented the binding of LiRAD51 on ssDNA
beads (Figure 7A, lane 5). The addition of LiBRCA2
alleviated the inhibitory effect of hRPA, and led to the
accumulation of LiRAD51 on ssDNA (Figure 7A, lanes
7–8). These results demonstrate that LiBRCA2 is a typical
recombination mediator. This might be accomplished
through interaction with hRPA (Figure 7B).
As LiBRCA2 is a recombination mediator, we therefore
tested whether it could also stimulate LiRAD51 strand
invasion ability. When limiting concentrations of
LiRAD51 were used, only limited D-loop products were
produced (Figure 7C, lane 3). However, when LiRAD51
was supplemented with LiBRCA2 (5–20 nM), strand
invasion occurred with a higher level than either protein
alone (Figure 7C, compare lanes 4–7 to lanes 2 and 3). No
D-loop was observed in the absence of ATP or supercoiled
DNA (Figure 7C, lanes 8 and 9). These results show that
LiBRCA2 promotes LiRAD51 activation in D-loop for-
mation, a key step in HR.
DISCUSSION
Mutations in BRCA1 or BRCA2 (BReast CAncer)
encoding genes lead to 10% of familial breast cancers
as well as increasing the risk of ovarian cancer. An
hallmark of these cancers is genomic instability,
characterized by an increase in chromosomal breaks and
translocations. In normal cells, this is suppressed by HR
which allows the faithful repair of DNA DSBs. The char-
acterization of RAD51 and BRCA2 in a simpler organism
such as L. infantum, now opens the door to biochemical
studies of several aspects of HR, genomic stability and
genetic variability.
We showed that LiBRCA2 possesses several critical
features important for the regulation of DNA recombin-
ation. First, using cytological analysis, we observed that
A
B
Figure 5. Comparison between LiRAD51 and hRAD51 D-loop activities. (A) Schematic representation of the D-loop assay using a 4.3-kb resected
dsDNA and supercoiled DNA templates. (B) Upper panel: D-loop reactions contained the 4.3-kb resected dsDNA with no protein (lane 1), or with
purified LiRAD51 (200–1200 nM, lanes 2–11). Lane 12 contains LiRAD51 (1200 nM) without supercoiled DNA (-ccc). Reactions with human
RAD51 (200–1200 nM, lanes 13–22); or human RAD51 (1200 nM) without supercoiled DNA (lane 23) are shown. Lower panel: quantification of
results presented in fold activation compared to the control at each protein concentration (nM). The asterisk represents annealed 30-tailed molecules.
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LiBRCA2 regulates the nuclear accumulation of
LiRAD51, suggesting a conserved mechanism of nuclear
transport by LiBRCA2 on LiRAD51. The large size of the
human BRCA2 protein (384 kDa) poses a great technical
challenge for biochemical analyses. To circumvent this
problem, we purified a BRCA2 homolog form L.
infantum which is three times smaller (125 kDa). One key
signature of human BRCA2, is eight conserved motifs of
approximately 35 amino acids, known as the BRC repeats.
We have analyzed the BRCA2 protein sequence of
Leishmania for the presence of these repeats and generated
a BRC repeats tree. Using this analysis we found that
L. infantum, T. cruzi, L. donovani, L. major, all possessed
two BRC repeats, very close to human BRC repeats 7 and
8. This is in contrast with T. brucei BRCA2 which
contains an expansion of 15 BRC repeats, which is
important for RAD51 localization and the efficiency of
T. brucei HR (46). LiBRCA2 also contains one OB-fold
domain and a putative Zn-Finger that is unique to the
Leishmania BRCA2. Recently, the function of the
human BRCA2 BRC repeats has been categorized based
on their functional mechanisms. BRC1,2,3,4 domains
bind to free RAD51 with high avidity, while BRC5, 6, 7,
8 bind poorly free RAD51, but bind the RAD51–ssDNA
filament with high affinity (42). Our results show that a
fragment of LiBRCA2 containing two BRC repeats
(related to human BRC repeats 3, 4, 7 and 8, respectively)
stimulates LiRAD51 binding to ssDNA, especially at
low LiBRCA2/LiRAD51 ratio. At higher LiBRCA2/
LiRAD51 ratios, the enhancement of LiRAD51 DNA
binding was reduced. This dual mode of regulation has
been reported where BRC3 peptide disrupted hRAD51
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Figure 6. DNA binding, annealing and interacting properties of LiBRCA2. (A) LiBRCA2 binds ssDNA preferentially over dsDNA. A 60-mer
ssDNA was incubated with increasing concentration (0–100 nM) of LiBRCA2 (lanes 1–7). (B) LiBRCA2 does not bind 60-mer dsDNA. A 60-mer
dsDNA was incubated with increasing concentration (0–100 nM) of LiBRCA2 (lanes 1–7) (C) LiBRCA2 promotes single-strand annealing. Lane 1,
purified 60-bp duplex DNA. Reactions (lanes 2–7) contained denatured 60-bp duplex DNA in buffer with an increasing concentration of LiBRCA2
(0–150 nM), lanes 2–7. (D–F) LiBRCA2 stimulates and disrupts LiRAD51–dsDNA complexes. (D) LiBRCA2 (0–20 nM) was added to pre-assembled
LiRAD51–ssDNA complexes (with LiRAD51 at a concentration of either 0 or 250 nM). (E) LiBRCA2 (0–120 nM) was added to pre-assembled
LiRAD51–dsDNA complexes (with LiRAD51 at a concentration of either 0 or 500 nM). (F) The N-terminus of LiBRCA2 affects LiRAD51
DNA-binding activity. Reactions (lanes 1–9) were conducted as in (D), but using none or 30 nM of LiRAD51 and LiBRCA2–B1 at concentrations
varying between 0 and 125 nM.
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nucleoprotein filaments at high concentration, but formed
stable complexes at lower concentration (47). As we
observed that LiRAD51 levels are very low compared to
LiBRCA2 without DNA damage, this suggests that
LiBRCA2 exerts a suppressive role on LiRAD51 in
normal conditions. However, when Leishmania is chal-
lenged with DNA damage, LiRAD51 levels are increased
substantially, suggesting that LiBRCA2 might enhance
LiRAD51-dependent recombination for DNA repair.
During the course of these studies, three independent
groups have purified full-length human BRCA2 (21–23).
Similar to LiBRCA2, it was shown that hBRCA2 is an
ssDNA-binding protein (21). However, D-loop formation
was not performed for the human BRCA2 protein. In
addition, only strand exchange reactions with oligonucleo-
tides, not full-length substrates, were reported. We
provide the first evidence of BRCA2 being able to stimu-
late RAD51-mediated HR by D-loop formation using
long DNA substrates. Our results suggest that the
minimal domain requirement for a BRCA2 protein to
function in such setting is two BRC repeats and an
OB-fold.
LiBRCA2 is a functional homolog of RAD52
Interestingly, RAD52 is absent in Leishmania and Saccha-
romyces cerevisiae does not bear a BRCA2 homolog. In
human cells, BRCA2 stimulates the assembly of RAD51
nucleoprotein filament. Saccharomyces cerevisiae does not
have a BRCA2 homolog and RAD52 is taking charge of
this function. Both proteins interact with RPA and
RAD51 and their dual inactivation lead to a synthetic
lethality phenotype in human cells, demonstrating that
both protein mediate pathways leading to RAD51 activa-
tion in mammalian cells (48). In Leishmania, RAD52 is
absent, and BRCA2 might also sustain the function of
RAD52 shown in lower organisms. We observed that
LiBRCA2 stimulated LiRAD51 for HR, and interacted
with LiRAD51 and human RPA. We have not used
Leishmania RPA or SSB, as the orthologs need to be
fully characterized. However, the functional interchange-
ability between RPA and SSB from different species is
supported by results indicating that SSB can substitute
for budding yeast and human RPA in strand exchange
mediated by S. cerevisiae and human RAD51, respectively
(49,50). Consistent with the observation that RAD52 de-
ficient cells accumulate genomic instability, we observed
that BRCA2 deficient-cells undergo chromosome loss. We
also found that LiBRCA2 is proficient in single-strand
annealing, a function normally attributed to RAD52
(10,51). Thus, our results add significant strength to the
idea that BRCA2 is a functional homolog of RAD52 in
Leishmania.
In order to characterize the function of LiBRCA2
in vivo, we inactivated BRCA2, and assessed HR and
cell survival. Gene targeting was severely affected in the
absence of LiBRCA2. RNAi approaches are not
A
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Figure 7. LiBRCA2 is a mediator molecule. (A) RPA (300 nM) bound to an ssDNA oligonucleotide prevents LiRAD51 (200 nM) assembly (lane 5),
whereas the addition of LiBRCA2 (0–30 nM) stimulates LiRAD51 DNA-binding activity in the presence of 300 nM hRPA (lanes 6–8). Background
controls demonstrating the interaction of hRPA (lane 1), LiBRCA2 (lane 2) and LiRAD51 (lane 3) on magnetic beads alone are also shown. The
reaction was conducted without ATP and Mg2+ in the presence of LiBRCA2, hRPA and LiRAD51 (lane 9). (B) Interaction between LiBRCA2 and
hRPA. LiBRCA2 (750 ng) and/or hRPA (1mg) were pooled together and coimmunoprecipitation experiments were performed using either IgG (lanes
1 and 2) or His (lanes 3–5) antibodies. Blots were reacted with the indicated antibodies. (C) LiBRCA2 stimulates LiRAD51-catalyzed D-loop
formation. Reactions contained DNA alone (lane 1); LiBRCA2 (20 nM, lane 2); LiRAD51 (250 nM, lanes 3–9); or a combination of both proteins
(lanes 4–9) with linear DNA molecule containing 30-single-strand tails (1 mM). Reactions 8 and 9, do not contain ATP (-ATP) or supercoiled DNA
(-ccc), respectively. The asterisk represents annealed 30-tailed molecules. At the bottom, the intensities of bands obtained for each D-loop reaction
were quantified in terms of fold activation compared to the control.
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functional in Leishmania (52), leading to the use of con-
ventional genetic inactivation. DNA integration in
Leishmania occurs predominantly by HR, whose efficiency
can be an obstacle to insertional mutagenesis strategies.
Collectively, as well as defining the functions of LiBRCA2
and LiRAD51, our work also shows that upregulation of
HR through overexpression of a recombinase gene might
be possible in this unicellular eukaryote.
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